<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection: 183 - 357</title>
  <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/9116" />
  <subtitle>183 - 357</subtitle>
  <id>http://localhost:8080/xmlui/handle/123456789/9116</id>
  <updated>2026-04-15T03:04:53Z</updated>
  <dc:date>2026-04-15T03:04:53Z</dc:date>
  <entry>
    <title>Low incidence of human coronavirus among hospitalized children in Novosibirsk city, Russia during pre-pandemic period (2013e2020)</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/9212" />
    <author>
      <name>Kurskaya, O.G.</name>
    </author>
    <author>
      <name>Prokopyeva, E.A.</name>
    </author>
    <author>
      <name>Anoshina, , A.V.</name>
    </author>
    <author>
      <name>Leonova, N.V.</name>
    </author>
    <author>
      <name>Simkina, , O.A.</name>
    </author>
    <author>
      <name>Komissarova, T.V.</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/9212</id>
    <updated>2024-12-18T02:52:28Z</updated>
    <published>2022-04-01T00:00:00Z</published>
    <summary type="text">Title: Low incidence of human coronavirus among hospitalized children in Novosibirsk city, Russia during pre-pandemic period (2013e2020)
Authors: Kurskaya, O.G.; Prokopyeva, E.A.; Anoshina, , A.V.; Leonova, N.V.; Simkina, , O.A.; Komissarova, T.V.
Abstract: Abstract We investigated the incidence of 15 respiratory viruses among 2991 children with&#xD;
acute respiratory infections in Novosibirsk city, Russia, prior to the COVID-19 pandemic (2013e2020). Viral infections were detected in 72.5% cases. The incidence of human coronavirus&#xD;
was 2% (Alphacoronaviruses, 63%; Betacoronaviruses, 37%).</summary>
    <dc:date>2022-04-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Hemodialysis acutely altered interferongamma release assay test result and immune cell profile</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/9205" />
    <author>
      <name>Utami Putri, Denise</name>
    </author>
    <author>
      <name>Chen, Chia-Ling</name>
    </author>
    <author>
      <name>-Hui Wang, Cheng</name>
    </author>
    <author>
      <name>Mou Sue, Yuh-</name>
    </author>
    <author>
      <name>Tseng, Po-Chun</name>
    </author>
    <author>
      <name>-Feng Lin, Chiou</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/9205</id>
    <updated>2024-12-18T02:43:01Z</updated>
    <published>2022-04-01T00:00:00Z</published>
    <summary type="text">Title: Hemodialysis acutely altered interferongamma release assay test result and immune cell profile
Authors: Utami Putri, Denise; Chen, Chia-Ling; -Hui Wang, Cheng; Mou Sue, Yuh-; Tseng, Po-Chun; -Feng Lin, Chiou
Abstract: Abstract Patients receiving hemodialysis (HD) are at risk of TB development. IGRA-positive&#xD;
patients showed significant decrease in quantitative IGRA result with alterations inCD3þCD4þCD45ROþ, NK cell, and monocyte subsets immediately upon HD procedure. Our&#xD;
result suggested that the timing of IGRA testing is crucial in end-stage renal disease population.</summary>
    <dc:date>2022-04-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Performance evaluation of newly developed fluorescence immunoassay-based interferon-gamma release assay for the diagnosis of latent tuberculosis infection in healthcare workers</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/9203" />
    <author>
      <name>Kweon, Oh Joo</name>
    </author>
    <author>
      <name>Kwan Lim, Yong</name>
    </author>
    <author>
      <name>Ryoun Kim, Hye</name>
    </author>
    <author>
      <name>-Hyoung Kim, Tae</name>
    </author>
    <author>
      <name>Lee, Mi-Kyung</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/9203</id>
    <updated>2024-12-18T02:42:09Z</updated>
    <published>2022-04-01T00:00:00Z</published>
    <summary type="text">Title: Performance evaluation of newly developed fluorescence immunoassay-based interferon-gamma release assay for the diagnosis of latent tuberculosis infection in healthcare workers
Authors: Kweon, Oh Joo; Kwan Lim, Yong; Ryoun Kim, Hye; -Hyoung Kim, Tae; Lee, Mi-Kyung
Abstract: Abstract The ichroma  IGRA-TB (Boditech Med Inc., Chuncheon, Republic of Korea) is an&#xD;
automated fluorescent immunoassay-based point-of-care interferon-gamma release assay for&#xD;
detecting latent tuberculosis infection. We evaluated this assay with 408 health care workers,&#xD;
and demonstrated its acceptable performances comparing to QuantiFERON-TB Gold-Plus (QFTPlus; Qiagen, Germantown, MD).</summary>
    <dc:date>2022-04-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/9200" />
    <author>
      <name>Cheng, Chao-Neng</name>
    </author>
    <author>
      <name>Li, Sin-Syue</name>
    </author>
    <author>
      <name>Yeh, Yun-Hsuan</name>
    </author>
    <author>
      <name>Shen, Ching-Fen</name>
    </author>
    <author>
      <name>-Shiuh Chen, Jiann</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/9200</id>
    <updated>2024-12-18T02:36:45Z</updated>
    <published>2022-04-01T00:00:00Z</published>
    <summary type="text">Title: Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan
Authors: Cheng, Chao-Neng; Li, Sin-Syue; Yeh, Yun-Hsuan; Shen, Ching-Fen; -Shiuh Chen, Jiann
Abstract: Abstract From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis.&#xD;
Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medication for use in cytomegalovirus prophylaxis in children.&#xD;
Further studies are warranted.</summary>
    <dc:date>2022-04-01T00:00:00Z</dc:date>
  </entry>
</feed>

